Disease name:	Cholangiocarcinoma
miRNA_name	PMID	Description	Causality
hsa-mir-21	32626749	To support, overexpression of miR-21 blocks galangin-mediated antisurvival and metastasis effects on CCA cells. Taken together, these findings indicate that galangin inhibits CCA cell proliferation and metastasis and induces cell apoptosis through a miRdependent manner, and galangin may provide a novel potential therapeutic adjuvant to treat CCA.	Unknown
hsa-mir-21	33805513	A three-marker model was constructed by using miR-21, miR-122 and CA19-9, which showed an AUC of 0.853 (95% CI: 0.824-0.879; sensitivity: 73.0%, specificity: 87.4%) to differentiate iCCA from controls.	Unknown
hsa-mir-21	32210627	CONCLUSION: Patients with HL-CCA show high incidence of hepatic abscess and elevated miRNA-21 and miRNA-221 expression level.	Unknown
hsa-mir-155	30653586	RESULTS Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation.	Unknown
hsa-mir-155	34876142	CONCLUSION: MiR-155-5p decreased the expression of SOX1 by binding to its 3'UTR, which activated the RAF/MEK/ERK signaling pathway and promoted CCA progression.	Unknown
hsa-mir-212	31837357	CONCLUSIONS: These findings suggest that aberrant hypermethylation-induced downregulation of miR3p results in overexpression of MUC13 in iCCA, leading to metastasis via activation of the EGFR/PI3K/AKT signaling pathway.	Unknown
hsa-mir-150	33161598	Thus, miRNA-150 can be considered as a non-invasive, sensitive serum biomarker for the diagnosis of CCA especially when combined with CA 19-9.	Unknown
hsa-mir-146a	33797690	These data demonstrated that SNHG16 promoted cell proliferation and repressed apoptosis by regulating the miR-146a-5p/GATA6 axis, which provides some helpful insights for the diagnosis and treatment of CCA.	Unknown
hsa-mir-92a	35157005	The expression of miR5p, miR-378d, miR5p, and miR-92a-3p was significantly higher in detached cell samples from smears of cholangiocarcinoma cases than in those from noncancer cases.	Unknown
hsa-mir-92a	31784323	Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p are potential biomarkers for discriminating CCA from BBD.	Unknown
hsa-mir-126	33639676	No association was found between miR3p expression and tumor subtypes (iCCA=0.42; pCCA=0.45; dCCA=0.72; P=0.9155).	Unknown
hsa-mir-19b	32315652	CONCLUSION: These results indicate that serum miR-19b-3p level is a crucial biomarker for ICC diagnosis and targeting miR-19b-3p-CCDC6 axis might be a promising strategy in ICC therapy.	Unknown
hsa-mir-182	35157005	The expression of miR5p, miR-378d, miR5p, and miR-92a-3p was significantly higher in detached cell samples from smears of cholangiocarcinoma cases than in those from noncancer cases.	Unknown
hsa-mir-182	32694937	MME-AS1 and hsa-miR-182 were associated with overall survival in ICC patients.	Unknown
hsa-mir-29b	30653586	RESULTS Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation.	Unknown
hsa-mir-122	30881509	It was also demonstrated that miRNA-122 exhibited significantly differential expression and the overall survival rate was predicted for various other types of cancer, including colorectal cancer, renal carcinoma, cholangiocarcinoma, prostate cancer and thyroid carcinoma.	Unknown
hsa-mir-122	31115511	Therefore, increasing miR122 expression and inhibiting PKM2 may be future approaches for cholangiocarcinoma treatment.	Unknown
hsa-mir-122	30653586	RESULTS Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation.	Unknown
hsa-mir-122	33805513	A three-marker model was constructed by using miR-21, miR-122 and CA19-9, which showed an AUC of 0.853 (95% CI: 0.824-0.879; sensitivity: 73.0%, specificity: 87.4%) to differentiate iCCA from controls.	Unknown
hsa-mir-200c	31933776	In conclusion, serum exosomal miR-200 family, particularly miR-200c-3p, could be efficient biomarkers for CCA. The serum levels of exosomal miR-200a/c-3p also represented the rate of CCA progression.	Unknown
hsa-mir-200c	31571907	The ability of migration of CCA cells was also up-regulated by Lnc-ATB but was suppressed by miR-200c.	Unknown
hsa-mir-200c	36091129	CONCLUSION: The bile exosomal miR-200 family, particularly miR-200c-3p, was verified to be a potential biomarker for the early detection of CCA.	Unknown
hsa-mir-96	32256758	miR-96 may represent an independent prognostic biomarker and may promote CCA cell proliferation, migration and invasion by targeting MTSS1.	Unknown
hsa-mir-361	31539122	Meanwhile, the suppression of miR-361-5p might improve CCA survival by targeting TRAF3 and inhibiting the NF-kappaB pathway, which might help to develop new strategies for CCA therapy.	Unknown
hsa-mir-124	30989656	Together, these findings demonstrate that UHRF1, regulated by miR3p, acts as a tumor promoter by promoting cell proliferation in ICC.	Unknown
hsa-mir-27a	32816152	Taken together, these results suggest the potential usefulness of miR-27a in the prognosis and progression of CCA.	Unknown
hsa-mir-27a	31956102	We concluded that the upregulation of lncRNA RP11-328K4.1, which might act as a miRNA sponge, exerts an antitumor effect in ICC by eliminating the inhibition of PROS1 mRNA expression by oncogenic miRNA hsa-miR-27a.	Unknown
hsa-mir-142	31007750	miR-142-5p may therefore have potential as a biomarker for screening patients with ICC from healthy controls.	Unknown
hsa-mir-144	32721879	The genes involved in RNA splicing and protein degradation processes and miR3p may play fundamental roles in the pathogenesis of CHOL.	Unknown
hsa-mir-144	33520692	Our findings indicated that miR-144-5p and miR-451a displayed a tumor suppressor role through decreasing the expression of ST8SIA4 in cholangiocarcinoma.	Unknown
hsa-mir-221	32210627	CONCLUSION: Patients with HL-CCA show high incidence of hepatic abscess and elevated miRNA-21 and miRNA-221 expression level.	Unknown
hsa-mir-218	31523056	Furthermore, we shed light on the underlying tumour promoting role and mechanism of COMMD6 by constructing a TEX41-miRCOMMD6 ceRNA network in head and neck squamous cell carcinoma and miRCDX1-COMMD6 transcriptional network in cholangiocarcinoma.	Unknown
hsa-mir-132	31638221	In conclusion, upregulation of miR1323p may serve a pivotal role in the tumorigenesis and progression of CCA by targeting different pathways.	Unknown
hsa-mir-340	31523056	Furthermore, we shed light on the underlying tumour promoting role and mechanism of COMMD6 by constructing a TEX41-miRCOMMD6 ceRNA network in head and neck squamous cell carcinoma and miRCDX1-COMMD6 transcriptional network in cholangiocarcinoma.	Unknown
hsa-mir-22	30856284	MIR22HG may be a novel target for diagnosis and therapy in CCA.	Unknown
hsa-mir-22	33193605	CONCLUSION: Based on the survival analysis, we conclude that DEPDC1, FUT4, MDK, PACS1, PIWIL4 genes, miR-22, miR-551b microRNAs, and cg27362525 and cg26597242 CpGs can strongly support their use as prognostic markers of CCA.	Unknown
hsa-mir-29a	33173343	It can promote the growth and metastasis of cholangiocarcinoma cells by inhibiting miR-29a, so it may be a new target for diagnosing and treating cholangiocarcinoma.	Unknown
hsa-mir-199a	34239888	Conclusion: Our findings indicated that SNHG12 inhibited cell proliferation and metastasis process of ICC cells through modulating the miR-199a-5p/Klotho axis and it is expected to become a potential therapeutic target for ICC.	Unknown
hsa-mir-7	34966644	CONCLUSIONS: The present findings suggest that miR-7-5p plays a pivotal role in ICC invasion by regulating MyD88.	Unknown
hsa-mir-29	30653586	RESULTS Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation.	Unknown
hsa-mir-192	30653586	RESULTS Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation.	Unknown
hsa-mir-192	33552829	CONCLUSION: MiR-192-5p promotes proliferation and suppressed apoptosis of CCA cells via the MEK/ERK pathway, which may be a potential therapeutic strategy for CCA treatment.	Unknown
hsa-mir-16	34632051	Taken together, our new findings suggested that IDH1 mutation-induced R-2HG could suppress CCA growth via regulating the FTO/m6A-methylated ERalpha/miR16-5p/YAP1 signaling pathway.	Unknown
hsa-mir-16	31443224	The validation phase confirmed downregulated miR-16 in patients with distal CCA compared to benign disease or PDAC (P = 0.048 and P = 0.012), while miR-877 was significantly upregulated (P = 0.003 and P = 0.006).	Unknown
hsa-mir-16	31641385	Furthermore, the lncRNAs H19 and PVT1, and the miRNAs Homo sapiens (hsa)-miR5p and hsa-miR5p, together with peroxisome proliferator-activated receptors, may also have important roles in the pathogenesis of CCA.	Unknown
hsa-mir-615	34182814	CircRNA_000585 is upregulated in CCA, and may function by a circRNA_000585/miR-615-5p/AMOT/YAP pathway, which may be a novel CCA pathway.	Unknown
hsa-let-7a	33750398	CONCLUSION: Taken together, the findings suggest the presence of a synergistic antitumor effect of miR-1182 and let-7a on the development of CCA via the down-regulation of NUAK1, providing novel insight into the targeted therapy against CCA.	Unknown
hsa-mir-20a	32801339	In conclusion, the present results demonstrate that lncRNA TTA-AS1 is a sponging ceRNA for miR-320a, which in turn downregulates neuropilin-1 in cholangiocarcinoma cells, indicating these three molecules represent potential biomarkers and therapeutic targets in the management of cholangiocarcinoma.	Unknown
hsa-mir-28	35965521	CONCLUSION: Lnc-PKD2-2-3/miR-328/GPAM ceRNA network promotes CCA proliferation, invasion, and 5-FU chemoresistance.	Unknown
hsa-mir-140	30764893	Collectively, these findings not only uncovered a key role of SNHG1/miR-140/TLR4/NF-kappaB signaling axis in CCA tumorigenesis and progression but also denoted the probable utilization of SNHG1 as a therapeutic target for CCA.	Unknown
hsa-mir-1	35157005	The expression of miR5p, miR-378d, miR5p, and miR-92a-3p was significantly higher in detached cell samples from smears of cholangiocarcinoma cases than in those from noncancer cases.	Unknown
hsa-mir-28	35670491	Specific CD44 special siRNA abrogated the discrepancy of the proliferation and metastasis capacity between miR-28-5p-overexpression CCA cells and their control cells, which further confirmed that CD44 was required in miR-28-5p-inhibited CCA cell growth and metastasis.	Unknown
hsa-mir-205	34926294	Quantitative real-time PCR (qRT-PCR) showed that expressions of CHRM3.AS2, MIR205HG, and LINC00661 were higher in CCA tissues than those in normal tissues, similar to the trends detected in the CCA dataset.	Unknown
hsa-mir-15a	35428780	Our data suggested that miR-15a-5p in HUCMSCs-exo suppresses EMT and metastasis of CCA through targeting downregulation of CHEK1.	Unknown
hsa-mir-30	31632586	We also showed that the expression level of miR5p in intrahepatic cholangiocarcinoma samples was downregulated compared to noncancerous tissues. Interesting, we proved that the miR5p expression was negative correlated with PCAT6 expression in intrahepatic cholangiocarcinoma.	Unknown
hsa-mir-101	35901327	miR3p, and miR3p Expression in Patients with INTRODUCTION: Cholangiocarcinoma (CCA) is the second most common type of primary liver cancer.	Unknown
hsa-mir-138	31663629	Here, we demonstrate that decreased miR-138 in tumor tissues is related to the poor prognosis in patients, and that miR-138 mediates sorafenib-induced cell survival in cholangiocarcinoma cells. Overall, the present study reveals that miR-138/SOX4 is involved in sorafinib-mediated cell survival in cholangiocarcinoma cells, and is associated with poor prognosis.	Unknown
hsa-mir-145	35901327	An increase in miR-145-3p expression level was observed in patients with perihilar CCA compared to those with distal CCA (0.51  0.41; 0.17  0.13; P = 0.0698).	Unknown
hsa-mir-145	34040387	CONCLUSION: This research suggested that the ST8SIA6-AS1/miR-145-5p/MAL2 axis could enhance CHOL progression, which might be useful to improve the clinical outcomes of CHOL patients.	Unknown
hsa-mir-145	33628035	CONCLUSION: CircDNM3OS facilitates CCA growth and glutamine metabolism by regulating the miR-145-5p/MORC2 pathway, offering a novel mechanism to understand the progression of CCA.	Unknown
hsa-mir-194	30514341	A combination of high-level TSPAN1 and low-level miR5p predicted poor prognosis in patients with CCA.	Unknown
hsa-mir-874	33476715	Therefore, the overexpression of miR-874 might bring favorable outcomes for the treatment of CC.	Unknown
hsa-mir-26a	32435051	CONCLUSIONS Bioinformatics analysis identified ESR1 and hsa-miR-26a-5p as potential prognostic biomarkers for intrahepatic cholangiocarcinoma.	Unknown
hsa-mir-148a	32054829	These results indicate that downregulation of miR-148a levels results in GLUT1 overexpression in iCCA, leading to iCCA progression and gemcitabine resistance.	Unknown
hsa-mir-216a	33544468	This study revealed that PCAT1 acted as an oncogene in CCA, and the YY1/PCAT1/miR-216a-3p/BCL3 axis exhibited critical functions in CCA progression.	Unknown
hsa-let-7g	35040749	This study aimed to identify the mechanisms of long non-coding RNA (lncRNA) TMPO Antisense RNA 1 (TMPO-AS1), microRNA let-7 g-5p, and high-mobility group A1 (HMGA1) proteins in CHOL. Our results, through quantitative real-time PCR and Western blot detection, showed that TMPO-AS1 and HMGA1 were overexpressed while let-7 g-5p was underexpressed in CHOL.	Unknown
hsa-mir-424	33436545	Moreover, silencing BCL9L or miR5p overexpression suppressed gemcitabine resistance, EMT, stemness and Wnt/beta-Catenin activation in resistant CCA cells.	Unknown
hsa-mir-424	36854894	The inhibition of miR5p reversed the HCG18 knockdown induced suppression on cholangiocarcinoma cancer cells. More specific, miR5p targeted to SOX9 contributed to cholangiocarcinoma growth and metastasis through mediating PI3K/AKT pathway.	Unknown
hsa-mir-424	31641385	Furthermore, the lncRNAs H19 and PVT1, and the miRNAs Homo sapiens (hsa)-miR5p and hsa-miR5p, together with peroxisome proliferator-activated receptors, may also have important roles in the pathogenesis of CCA.	Unknown
hsa-mir-186	33502823	In conclusion, NEAT1 was involved in cell proliferation, migration and invasion in CCA, and the NEAT1/miR-186-5p/PTP4A1/PI3K/AKT axis indicated novel regulatory mechanisms and therapeutics for the treatment of CCA.	Unknown
hsa-mir-186	31180332	MiR5p could influence CCA cell proliferation, migration and metastasis by regulating MORC2.	Unknown
hsa-mir-186	32812642	All in all, SOX2 down-regulated miR-186 through the transcriptional activation of lncRNA PVT1, whereas elevating SEMA4D expression, thus promoting the progression of CCA.	Unknown
hsa-mir-183	35106794	Exosomal miR-183-5p is a potential predictive biomarker for ICC progression and a potential target for development of therapeutic strategies against immune tolerance feature of ICC.	Unknown
hsa-mir-485	31404302	Mechanistically, FLVCR1-AS1 was demonstrated to sponge microRNA5p (miR5p) in human CCA. The expression of miR5p was significantly decreased in CCA tissue compared with normal tissue, and Pearson's correlation analysis revealed that FLVCR1-AS1 expression was negatively correlated with miR5p expression in CCA tissues.	Unknown
hsa-mir-485	31616187	Finally, rescue assays verified that NNT-AS1 modulated the tumorigenesis of CCA by regulating miR-485. Our results elucidated NNT-AS1/miR-485/BCL9 axis might lead to a further understanding of the molecular mechanism of CCA.	Unknown
hsa-mir-24	31003776	Moreover, luciferase reporter and rescue assays indicated that LOXL1-AS1 functioned as a ceRNA to elevate ATP-binding cassette transporter A1 (ABCA1) level by sponging miR3p and exhibited the malignant phenotypes of CCA cells, thereby playing an oncogenic role in CCA.	Unknown
hsa-mir-455	34149934	These findings establish an essential role of miR-455-5p in CCA development and galangin may provide a potential therapeutic adjuvant agent for anti-CCA treatment.	Unknown
hsa-mir-451	36352360	miR-451 also suppressed the progression of cholangiocarcinoma, which provides a potential therapeutical target for cholangiocarcinoma treatment.	Unknown
hsa-mir-378	30594918	The miR-378 could be a novel prognostic marker for CCA.	Unknown
hsa-mir-98	32062383	In conclusion, HEIH promoted CHOL tumorigenesis and progression by miR5p/HECTD4 axis, which opens up a new insight for CHOL therapeutics.	Unknown
hsa-mir-20	32801339	In conclusion, the present results demonstrate that lncRNA TTA-AS1 is a sponging ceRNA for miR-320a, which in turn downregulates neuropilin-1 in cholangiocarcinoma cells, indicating these three molecules represent potential biomarkers and therapeutic targets in the management of cholangiocarcinoma.	Unknown
hsa-mir-451a	33520692	Our findings indicated that miR-144-5p and miR-451a displayed a tumor suppressor role through decreasing the expression of ST8SIA4 in cholangiocarcinoma.	Unknown
hsa-mir-432	35091535	In conclusion, Circ_0020256 in TAM-secreted exosomes promoted the proliferation, migration, and invasion of CCA cells, and that promotional activity was regulated via a Circ_0020256/miR-432-5p/E2F3 axis.	Unknown
hsa-mir-23a	35200104	Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with Dynamin3.	Unknown
hsa-mir-34c	34261453	BACKGROUND: This study aimed to investigate the exact regulatory mechanisms of exosomal miR-34c in mediating communication between cholangiocarcinoma cells and fibroblasts. Additionally, cancer-associated fibroblasts (CAFs) activated by downregulation of exosomal miR-34c promoted cholangiocarcinoma progression.	Unknown
hsa-mir-152	36331285	CONCLUSION: Circ_0000284 promoted the growth, metastasis and glycolysis of ICC by miR-152-3p/PDK1 pathway, showing that circ_0000284 was a potential therapeutic target for ICC.	Unknown
hsa-mir-506	32694946	Rescue assays verified that linc00473 modulated the tumorigenesis of CCA by regulating miR-506.	Unknown
hsa-mir-541	34974242	CONCLUSION: CircRTN4IP1 knockdown inhibited ICC cell malignancy by miR-541-5p/HIF1A axis, providing us with a reliable target for the therapy of ICC.	Unknown
hsa-mir-376a	35022330	Simultaneously, PSMA3-AS1 primarily localized in the cytoplasm could competitively bind miR-376a-3p to upregulate LAMC1, thereby accelerating CCA progression. This study uncovers that PSMA3-AS1 functions as a cancer-promoting gene in CCA, and PAX5/PSMA3-AS1/miR-376a-3p/LAMC1 axis plays a vital role in CCA development.	Unknown
hsa-mir-3173	34647226	Furthermore, using RNA pulldown and dual luciferase assays, the interactions between SNHG3 and miR5p and between miR5p and ERG in CCA cells were validated. Knockdown of SNHG3 expression suppressed malignant phenotypes in CCA cells via the miR5p/ERG axis.	Unknown
hsa-mir-885	33052627	Collectively, we demonstrated that miR-885-5p was an important mediator of iCCA proliferation and metastasis by regulating GALNT3 and IGF2BP1, thus offering a potential target for iCCA treatment.	Unknown
hsa-mir-877	31443224	The validation phase confirmed downregulated miR-16 in patients with distal CCA compared to benign disease or PDAC (P = 0.048 and P = 0.012), while miR-877 was significantly upregulated (P = 0.003 and P = 0.006).	Unknown
hsa-mir-95	36727735	CircRNA SMARCA5 is involved in CHOL development by interosculating miRNA-95-3p/TRAF3 axis and may become a novel approach for treating CHOL.	Unknown
hsa-mir-648	36114826	SKI protein expression was decreased in human CC cells overexpressing miRNA-3648, endogenous SKI protein expression was decreased in human CC tumor tissues, and endogenous SKI mRNA expression was suppressed in human CC cells characterized by rapid growth.	Unknown
hsa-mir-551b	31199052	In summary, miR-551b-3p inhibits the expression of CCND1 to suppress CCA cell proliferation and induce apoptosis, which may provide a theoretical basis for improving CCA treatment.	Unknown
hsa-mir-551b	33193605	CONCLUSION: Based on the survival analysis, we conclude that DEPDC1, FUT4, MDK, PACS1, PIWIL4 genes, miR-22, miR-551b microRNAs, and cg27362525 and cg26597242 CpGs can strongly support their use as prognostic markers of CCA.	Unknown
hsa-mir-514a	32750152	For CCA cells, circ-CCAC1 increased cell progression by sponging miR-514a-5p to up-regulate Yin Yang 1 (YY1).	Unknown
hsa-mir-612	32505707	Taken together, HIF1alpha activated lncRNA H19-mediated miR-612/Bcl-2 pathway to promote cholangiocarcinoma, suggesting a promising therapeutic target for cholangiocarcinoma.	Unknown
hsa-mir-612	30967271	Besides, LINC01061 existing in the cytoplasm of CCA cells interacted with miR-612. To sum up, our present exploration demonstrated that LINC01061 sponges miR-612 so as to upregulate SEMA4D expression for the progression of CCA, suggesting an optional promising and effective target for the therapy of patients with CCA.	Unknown
hsa-mir-876	31409772	This study demonstrates a novel tumor suppressor role for miR-876 in CCA, identifies BCL-XL as an actionable target, and suggests a potential therapeutic role for miR-876 in CCA.	Unknown
hsa-mir-1182	33750398	CONCLUSION: Taken together, the findings suggest the presence of a synergistic antitumor effect of miR-1182 and let-7a on the development of CCA via the down-regulation of NUAK1, providing novel insight into the targeted therapy against CCA.	Unknown
hsa-mir-520f	32907346	Conclusion: These data confirmed the knockdown SNHG20 expression in CCA could inhibit the proliferation by means of sponging miR-520f-3p.	Unknown
hsa-mir-124	35978818	Exosomal miR-3124-5p and GDF11 could be promising biomarkers or therapeutic targets for CHOL.	Unknown
hsa-mir-200b	36728287	CONCLUSION: L-Fucose inhibited the progression of CCA via the miR-200b/MAPK7 and signal transducer and activator of transcription 3 signaling pathways.	Unknown
hsa-mir-21	32913463	By analyzing the TCGA dataset, we found that expression of miR-21, an oncogene and a potential target of anticancer drugs for cholangiocarcinoma, was upregulated in cholangiocarcinoma tissues compared to paired control tissues. Taken together, our study demonstrates that dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis in cholangiocarcinoma cells via regulating miR-21.	Unknown
hsa-mir-92a	34828265	To elucidate the detailed regulatory mechanism, miR-92a-3p is screened and identified as a negative regulatory small RNA targeting NOV, and further experimental validation demonstrates that miR-92a-3p contributes to NOV-mediated migration and invasion of ICC via the Notch signaling pathway.	Unknown
hsa-mir-29b	33601338	These findings suggest miR-29b functions as a tumor suppressor in cholangiocarcinoma by relieving DNMT3B-mediated repression of CDKN2B expression.	Unknown
hsa-mir-29b	32790250	CONCLUSIONS: The DHA and miR-29b have a pro-apoptotic effect on cholangiocarcinoma cells through the DHA/miR-29b/Mcl-1 pathway, possibly by upregulating the expression of the pro-apoptotic protein Mcl-1S and thus increasing the proportion of Mcl-1S protein among the total amount of Mcl-1 protein.	Unknown
hsa-mir-122	31106658	LncRNA-UCA1 promoted the metastasis of BDC cells by regulating the expression of miR-122 and its downstream gene mRNA CLIC1 and promoted the activation of the ERK/MAPK pathway, which expanded the horizons of targeted therapy of cholangiocarcinoma.	Unknown
hsa-mir-122	31258634	In conclusion, the present study demonstrates that the lncRNA UCA1 promotes ICC cell proliferation and invasion at least in part by targeting miR-122, suggesting that the UCA1/miR-122 interaction may become a potential therapeutic target for the treatment of ICC.	Unknown
hsa-mir-122	36348252	In addition, miR5p was found to act as a post-transcriptional regulator of FUT8 and proved to inhibit FUT8 expression and then suppress the proliferation and migration ability of iCCA cell lines. CONCLUSIONS: These findings demonstrated that FUT8, regulated by miR5p, could be a tumor promoter of iCCA through PI3K/AKT signaling pathway.	Unknown
hsa-mir-206	34240323	CONCLUSION: Altogether, our findings clarified that miR-206 inhibited CCA malignancy by negatively regulating JARID2.	Unknown
hsa-mir-200c	33040228	In addition, LINC00667 was demonstrated to function as a ceRNA for miR-200c-3p, and then LINC00667 up-regulated pyruvate dehydrogenase kinase 1 (PDK1) to promote CCA development by inhibiting miR-200c-3p. Targeting the YY1/LINC00667/miR-200c-3p/PDK1 axis may provide a new therapeutic strategy for CCA treatment.	Unknown
hsa-mir-18a	33557774	MiR-18a-5p was increased in intrahepatic cholangiocarcinoma samples, and its expression was negatively correlated with that of MT1JP. CONCLUSIONS: MT1JP alleviated proliferation, migration and invasion, and induced apoptosis in cholangiocarcinoma cells by regulating miR-18a-5p/FBP1 axis.	Unknown
hsa-mir-149	35864972	YAP1 promoted CCA proliferation, invasion and stemness maintenance, whereas miR5p inhibited malignant biological behavior of CCA. These findings indicated that YY1-induced DLEU1 played a crucial role in CCA progression via miR5p/YAP1/TEAD2/SOX2 axis.	Unknown
hsa-mir-23b	33913242	These findings contribute to understanding the influences of LINC00184, miR-23b-3p, and ANXA2 on cholangiocarcinoma and provide basis for cholangiocarcinoma treatment.	Unknown
hsa-mir-27a	36848245	MiR-27a-3p arises as an oncogenic vulnerability in CCA.	Unknown
hsa-mir-27a	33552968	In summary, our results highlighted the important role of the lncRNA-PAICC-miR3p/27a-3p-Yap1 axis in ICC, which offers a novel perspective on the molecular pathogenesis and may serve as a potential target for antimetastatic molecular therapies of ICC.	Unknown
hsa-mir-142	31632521	Mechanistically, we demonstrated that NNT-AS1 might function as a ceRNA in regulating HMGA2 (high mobility group AT-hook 2) through competitively binding to miR5p in CCA. CONCLUSION: In summary, these findings suggest the potential prognostic and therapeutic value of NNT-AS1/miR5p/HMGA2 axis in CCA patients.	Unknown
hsa-mir-144	32710569	In addition, we identified miR-451a and miR3p as putative tumour suppressors attenuating cell migration by inhibiting ATF2 in the process of dCCA tumorigenesis.	Unknown
hsa-mir-34a	34999254	miR-34a-5p directly targeted WNT7B and inhibited WNT7B expression.	Unknown
hsa-mir-340	36473706	CONCLUSION: Hsa_circ_0,019,054 deficiency could attenuate the proliferation and glycolysis of ICC cells via miR-340-5 p/HIF1A axis.	Unknown
hsa-mir-340	33491760	In conclusion, the present study indicated that aspirin partially inhibited cholangiocarcinoma cell proliferation and tumor growth by inducing G0/G1 phase cell cycle arrest, potentially through the miR3405p/cyclin D1 axis.	Unknown
hsa-mir-29a	34199886	Downregulation of the miR-29-3p-family enhanced SP1-mediated ITGA6/ITGB1 expression in ICC cells.	Unknown
hsa-mir-29	34199886	Downregulation of the miR-29-3p-family enhanced SP1-mediated ITGA6/ITGB1 expression in ICC cells.	Unknown
hsa-mir-204	32755793	CONCLUSION: These data unraveled that lncRNA HOTAIR regulated HMGB1 to suppress cell apoptosis, autophagy and induce cell proliferation by sponging miR-204-5p in CCA.	Unknown
hsa-mir-181b	34169384	The present data indicated miR-181b-5p acted as an oncogene in CCA through promoting tumor cell proliferation, migration, and invasion of CCA via the PTEN/PI3K/AKT signaling pathway by targeting PARK2, which might be a promising therapeutic target or biomarker for CCA.	Unknown
hsa-mir-345	34232945	The E2F1/LMCD1-AS1/miR5p/COL6A3 axis is a newly identified regulatory mechanism, which has a function in cholangiocarcinoma (CCA) tumorigenesis and progression and provides potential therapeutic targets for CCA.	Unknown
hsa-mir-345	32196584	CONCLUSIONS: In this study, we verified that LncRNA DANCR affected cell proliferation, migration, invasion, angiogenesis, epithelial-mesenchymal transition (EMT) and induced apoptosis through modulating miR-345-5p/Twist1 axis in Cholangiocarcinoma.	Unknown
hsa-mir-345	30876691	In addition, LMCD1-AS1 could sponge miR5p in CCA cells. Taken together, we reported a newly identified regulatory mechanism of E2F1/LMCD1-AS1/miR5p/COL6A3 axis, which might lead to a better understanding of CCA tumorigenesis and progression and provide potential therapeutic targets for CCA.	Unknown
hsa-mir-210	36454533	Our current study highlighted that tumor cell-derived EVs could deliver miR-210 to CCA cells, where miR-210 specifically decreases RECK expression, which facilitates growth, metastasis and chemoresistance in CCA.	Unknown
hsa-mir-141	33552968	In summary, our results highlighted the important role of the lncRNA-PAICC-miR3p/27a-3p-Yap1 axis in ICC, which offers a novel perspective on the molecular pathogenesis and may serve as a potential target for antimetastatic molecular therapies of ICC.	Unknown
hsa-mir-582	35274813	Finally, we showed that YAP1 was a target of NKILA via miR3p and NKILA functioned partially via YAP1 in CCA.	Unknown
hsa-mir-137	31985024	Therefore, the findings of the present study demonstrated that miR137 acts as a suppressor in CCA and inhibits CCA cell proliferation, migration and invasion through suppressing the expression of WNT2B.	Unknown
hsa-mir-194	31960990	In a word, miR-194 inhibits ECT2 and blocks the activation of Rho signaling pathway, thus promoting apoptosis, inhibiting proliferation and migration of CCA stem cells, and suppressing tumor growth.	Unknown
hsa-mir-10a	30410355	These results   indicate that miR-10a-5p may serve as a potential target for the treatment of CCA   and help to develop effective therapeutic strategies.	Unknown
hsa-mir-326	35248826	Functionally, circ_0000591 induced the proliferation, migration and invasion of CCA cells through sponging miR-326. In conclusion, this study revealed a novel regulatory mechanism that circ_0000591 contributed to the progression of CCA via miR-326/TLR4/MyD88/IL6 axis.	Unknown
hsa-mir-146b	34610483	CONCLUSION: MiR-146b-5p is a cholangiocarcinoma suppressor by inhibiting cell proliferation and promoting cell apoptosis with targeting TRAF6, possibly via modulating p53 translocation to mitochondria.	Unknown
hsa-mir-424	31360102	Targeting the pathway described here may be a novel approach to inhibit metastasis of ICC and the restoration of miR-424-5p expression may be a promising strategy for ICC therapy.	Unknown
hsa-mir-186	34337058	Overall, these results demonstrated that the lncRNA PVT1/miR186/KLF5 axis might exert a key role in the occurrence and progression of CCA, and this axis might provide a new target for treating CCA.	Unknown
hsa-mir-186	31072421	Thus, miR-186/Twist1 axis may benefit the development of therapies for CCA.	Unknown
hsa-mir-455	34539879	In conclusion, DMY suppresses tumor growth and EMT through regulating miR-455-3p in human cholangiocarcinoma, suggesting a potential option for CCA treatment.	Unknown
hsa-mir-490	30886152	In addition, Akirin2 expression was negatively controlled by miR3p in CCA cells, and miR3p attenuated cell migration and angiogenesis in CCA cells by silencing Akirin2. Taken together, the data indicated that Akirin2 could be regulated by miR3p at the posttranscriptional level and facilitate CCA cell progression via the IL-6/STAT3/VEGFA signaling pathway.	Unknown
hsa-mir-505	33301605	In summary, the DLGAP1-AS2/miR-505/GALNT10 axis may contribute to regulating the malignant progression of CCA and may have potential as a novel target for CCA therapy.	Unknown
hsa-mir-421	35435120	These findings demonstrate that circSETD3 inhibits proliferation and induces apoptosis in CCA cells by regulating the miR-421/BMF axis, indicating its potential as a promising candidate for CCA therapy.	Unknown
hsa-mir-513a	34903127	TTN-AS1 induced CCA cell growth and metastasis via the miR-513a-5p/SFN pathway, which offers a new strategy for therapeutic interventions for CCA.	Unknown
hsa-mir-451a	32710569	In addition, we identified miR-451a and miR3p as putative tumour suppressors attenuating cell migration by inhibiting ATF2 in the process of dCCA tumorigenesis.	Unknown
hsa-mir-129-2	32231727	These results will aid in elucidating the roles of miR-129-2-3p in ICC, and suggest that this miRNA may provide a potential target for the treatment of ICC.	Unknown
hsa-mir-432	34898474	The promoting effect of circ-ZNF609 on cholangiocarcinoma is achieved via oncogene LRRC1 up-regulation through targeting miR5p by endogenous competitive RNA mechanism. Overall, YY1/eIF4A3/circ-ZNF609/miR5p/LRRC1 have a significant role in progression of cholangiocarcinoma, and circ-ZNF609 is expected to become a novel biomarker for targeted therapy and prognosis evaluation of cholangiocarcinoma.	Unknown
hsa-mir-196	35466323	In summary, we successfully depict the oncogenic role of miR-196-5p in promoting cell proliferation and migration in CCA via HAND1/Wnt/beta-catenin axis.	Unknown
hsa-mir-188	36121635	However, interfering MALAT1-miR-188-5p-PSMD10 axis could inhibit the occurrence and development of cholangiocarcinoma.	Unknown
hsa-mir-296	31565837	In conclusion, ZFAS1 might promote cholangiocarcinoma proliferation and metastasis by modulating USF1 via miR5p.	Unknown
hsa-mir-541	31590696	Dicer silencing down-regulated miR5p and miR5p expression, which targeted and promoted CyclinD1 and CDK6 expression in ICC cells. CONCLUSIONS: Our findings uncover that CyclinD1 inhibits Dicer expression by chromatin modification to reduce miR5p/miR5p expression, which positively-feedback enhances CyclinD1 and CDK6 expression and progression of ICC.	Unknown
hsa-mir-1914	31590696	Dicer silencing down-regulated miR5p and miR5p expression, which targeted and promoted CyclinD1 and CDK6 expression in ICC cells. CONCLUSIONS: Our findings uncover that CyclinD1 inhibits Dicer expression by chromatin modification to reduce miR5p/miR5p expression, which positively-feedback enhances CyclinD1 and CDK6 expression and progression of ICC.	Unknown
hsa-mir-133b	31978895	In addition, malignant phenotypes of CCA promoted by ZEB1-AS1 dysregulation were rescued separately through interfering miR-133b and HOXB8, suggesting AR/ZEB1-AS1/miR-133b/HOXB8 exerted crucial functions in tumorigenesis and progression of CCA.	Unknown
hsa-mir-29	30582202	To summarize, miR-329 inhibited the expression of PTTG1 to inactivate the MAPK signaling pathway, thus suppressing the CCA progression, thereby providing a therapeutic basis for the CCA treatment.	Unknown
hsa-mir-520c	32857725	SP1/HOXD-AS1/miR-520c-3p/MYCN plays a vital role in initiation and progression of CCA, and HOXD-AS1 is expected to be an efficient biomarker and therapeutic target.	Unknown
hsa-mir-1297	33790648	"In addition, the function study showed that GAS5 acted as a ""sponge"" to downregulate hsa-miR-1297, thus modulating CCA cell proliferation and invasion. CONCLUSION: GAS5 acts as an endogenous sponge of hsa-miR-1297 to promote CCA cell proliferation and invasion, which might be a potential biomarker and therapeutic target for CCA."	Unknown
hsa-mir-629	35490654	CONCLUSION: Upregulation of circ_0059961 augmented SFRP2 expression by targeting miR5p, which blocked cholangiocarcinoma tumor cell proliferation, migration, and invasion.	Unknown
hsa-mir-744	35346892	TM4SF1-AS1 served as tumor promoter of CCA via modulating miR-744-3p.	Unknown
hsa-mir-885	34170484	METHODS: Western blot and qRT-PCR assays were used to assess the expression of myotrophin (MTPN) and microRNA5p (miR5p) in CCA tissues and cells. CONCLUSION: Our data indicate that the ATO/miR5p/MTPN axis may serve as a target for improving the sensitivity of CCA cells to chemotherapy.	Unknown
hsa-mir-1236	34526098	By SILAC and circRNA-pull down, we demonstrated that circHMGCS1-016 induced ICC cell invasion and reshaped the tumor immune microenvironment via the miR3p/CD73 and GAL-8 axis. CONCLUSIONS: CircHMGCS1-016 is a forceful contributor in ICC development and immune tolerance via miR3p/CD73 and GAL-8 axis.	Unknown
hsa-mir-637	34290981	In all, HOTTIP modulates the sensitivity to CG in CCA through the HOTTIP/miR-637/LASP1 regulatory axis, providing a new opportunities for CCA treatment.	Unknown
hsa-mir-551b	32064660	Mechanistically, MIAT directly interacted with miR-551b-3p and inversely modulated miR3p level in CCA cells. MIAT contributed to the growth of CCA cells by targeting miR-551b-3p/CCND1 axis.	Unknown
hsa-mir-373	32125086	miR-373 targeted ULK1 to initiate inhibition of autophagy and subsequent promotion of apoptosis in cholangiocarcinoma cells.	Unknown
hsa-mir-493	36369960	Overall, our data suggest that CAFs in the ICC TME suppress CARTPT in tumor cells and promote tumor cells via miR-493-5p in EVs.	Unknown
hsa-mir-202	36400758	Mechanistically, linc00976 competitively interacted with miR-3202 to upregulate GPX4 expression, thus contributing to the malignant biological behavior of CCA cells. Accordingly, JUND promotes linc00976 transcription, and linc00976 plays a crucial role in accelerating CCA tumorigenesis and metastasis and inhibiting ferroptosis by modulating the miR-3202/GPX4 axis.	Unknown
hsa-mir-641	32423991	CDR1as and miR-641 could be considered therapeutic targets for CCA.	Unknown
hsa-mir-3913	33490245	Therefore, miR-3913 may serve as a biomarker for the diagnosis and prognosis of patients with CCA.	Unknown
hsa-mir-1	28098904	has-miR-96, has-miR-1 and has-miR-25, may be potential therapeutic targets for the future treatment of ICC	NO
hsa-mir-101	26299768	In conclusion, the present study identified important roles for miR-101 and VEGF-C in ICC, suggesting that miR-101/VEGF-C signaling may be a promising diagnostic and/or therapeutic target for ICC.	YES
hsa-mir-103	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-106a	26534789	Together, reduced expression of serum miR-106a is a powerful prognostic indicator for CCA patients. The dismal outcome of these CCA patients might correlate with a higher risk of lymph node metastasis.	NO
hsa-mir-106b	29286255	miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family	NO
hsa-mir-106b	28881782	miR-106b regulates the 5-fluorouracil resistance by targeting Zbtb7a in cholangiocarcinoma	NO
hsa-mir-122	27472451	MiR-122 overexpression reduced cell invasion and migration ability, and inhibited cell apoptosis and p53 expression. Inhibiting miR-122 caused the opposite results.	YES
hsa-mir-122	26686459	MiR-122 expression was significantly weaker in CC tissues, and miR-122 overexpression might play pivotal roles in inhibiting proliferation, stimulating apoptosis and suppressing invasion of CC cells, suggesting a new target for CC diagnosis and treatment.	YES
hsa-mir-122	26825606	The results indicate that HNF6 may serve as a tumor suppressor by regulating miR-122, and its overexpression may represent a mechanism-based therapy for CCA.	NO
hsa-mir-122	28832247	miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.	NO
hsa-mir-124-1	22819820	Epigenetic regulation of miR-124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.	NO
hsa-mir-124-2	22819820	Epigenetic regulation of miR-124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.	NO
hsa-mir-125b	26455324	We also found that enforced expression of let-7c, miR-99a or miR-125b could reduce the activity of STAT3 and further suppress CCA tumorigenicity in vivo and inhibit the migration and invasion of CCA cells in vitro.	YES
hsa-mir-126	23458262	Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma	NO
hsa-mir-126	30042823	High miR-126, low miR-128 and TEMs were independent prognostic factors for recurrence-free and overall survival	NO
hsa-mir-1275	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-128	30042823	High miR-126, low miR-128 and TEMs were independent prognostic factors for recurrence-free and overall survival	NO
hsa-mir-138	23446431	Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.	NO
hsa-mir-141	17355635	These include miR-200b and miR-141 which have been shown to be highly overexpressed in malignant cholangiocytes and in colon carcinoma.	NO
hsa-mir-141	16762633	MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes.	NO
hsa-mir-141	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-144	25479763	miR-144 was reduced in CCA tissues and suggested that miR-144 may be an essential suppresser of CCA cell proliferation and invasion through targeting LIS1.	YES
hsa-mir-145	26255969	MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.	YES
hsa-mir-146a	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-146a	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-146b	29095255	Both plasma and tumor tissue miR-146a high expression correlates with prolonged overall survival of surgical patients with intrahepatic cholangiocarcinoma.	NO
hsa-mir-148a	20146264	These data indicate that IL-6 can regulate the activity of DNMT-1 and expression of methylation-dependent tumor suppressor genes by modulation of miR-148a and miR-152, and provide a link between this inflammation-associated cytokine and oncogenesis in cholangiocarcinoma.	YES
hsa-mir-150	27658773	Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.	NO
hsa-mir-150	25482320	combination of these two markers improved the power of screening ICC. Moreover, on the basis of the plasma miR-150 level, 15 ICC patients were divided into a low or high expression group. We found that plasma miR-150 is a potential diagnostic biomarker for ICC.	NO
hsa-mir-151	23458262	Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma	NO
hsa-mir-152	20146264	These data indicate that IL-6 can regulate the activity of DNMT-1 and expression of methylation-dependent tumor suppressor genes by modulation of miR-148a and miR-152, and provide a link between this inflammation-associated cytokine and oncogenesis in cholangiocarcinoma.	YES
hsa-mir-155	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-16	28915618	Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma.	YES
hsa-mir-17	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-18	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-181c	27533020	Down-regulation of NDRG2 and overexpression of miR-181c or LIF are significantly associated with a poorer overall survival (OS) in CCA patients.	NO
hsa-mir-191	30235453	miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma.	NO
hsa-mir-192	26456596	We found that miR-192 was significantly higher in O. viverrini infected, PDF and also CCA groups (p<0.05) than in healthy controls.	NO
hsa-mir-192	25131257	This finding indicates that elevated levels of miR-192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients.	NO
hsa-mir-193a	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-194	26864161	miR-483-5p and miR-194 showed deregulated expression in CC compared with controls.	NO
hsa-mir-195	27474881	Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.	NO
hsa-mir-199	25217977	the cell proliferation and inhibition of tumor suppression mediated by these miRNAs is common to both cancerous and non-cancerous cells.	NO
hsa-mir-199a	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-199b	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-199b	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-19a	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-19b-1	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-200a	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-200a	26586458	MiR-200a may suppress the proliferative and invasive ability of REB cells. The reduced miR-200a expression might be correlated with the development and progression of CCA.	NO
hsa-mir-200a	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-200b	17355635	These include miR-200b and miR-141 which have been shown to be highly overexpressed in malignant cholangiocytes and in colon carcinoma.	NO
hsa-mir-200b	24169343	Our study shows that miR-200b/c has a critical role in the regulation of the tumorigenic and metastatic capacity of cholangiocarcinoma and reveals the probable underlying mechanisms.	NO
hsa-mir-200b	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-200b	16762633	MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes.	NO
hsa-mir-200b	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-200c	26864161	miR-200c was found to be expressed differentially in PSC versus controls	NO
hsa-mir-200c	22707408	Inactivation of miR-200c resulted in an induction of EMT, whereas activation of miR-200c led to a reduction of EMT including a reduced cell migration and invasion in ICC cells.	NO
hsa-mir-200c	24169343	Our study shows that miR-200b/c has a critical role in the regulation of the tumorigenic and metastatic capacity of cholangiocarcinoma and reveals the probable underlying mechanisms.	NO
hsa-mir-200c	26855082	The ability of the combined PCX/miR-200c treatment to obstruct two migratory pathways represents a promising antimetastatic strategy in cholangiocarcinoma.	NO
hsa-mir-200c	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-203	26464713	Our findings suggest that miR-203 expression was an independent poor prognostic factor for CCA patient overall survival. Therefore, miR-203 may serve as a valuable prognostic marker and promising treatment target for CCA.	NO
hsa-mir-204	24280681	These findings suggest that miR-204 plays negative roles in the invasive and/or metastatic potential of ICC, and that its suppressive effects are mediated by repressing Slug expression.	YES
hsa-mir-205	24147037	miRNA expression profiling was used to identify key miRNAs that regulate Gem sensitivity in CCA cells, and software that predicts miRNA targets was used to identify promising target genes for anti-tumor therapies.	NO
hsa-mir-205	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-20a	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-21	27685844	Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.	NO
hsa-mir-21	26456596	MiR-21 was significantly higher in PDF and CCA groups (p<0.05) than in healthy controls.	NO
hsa-mir-21	29516989	serum miR-21 was a promising biomarker for diagnosing the late stage CCA and would have potential to be a useful prognostic biomarker of CCA	NO
hsa-mir-21	25769721	anti-miR-21 treatment reduced liver tumor growth and prevented tumor development.	YES
hsa-mir-21	22213145	Based on our data, we conclude that Ars2 is overexpressed in human CCA and may be a diagnostic marker. Ars2 depletion increases PTEN and PDCD4 protein levels via the reduction of miR-21.	NO
hsa-mir-21	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-21	28197636	miR-21 and KLF4 jointly augment epithelial‑mesenchymal transition via the Akt/ERK1/2 pathway.	NO
hsa-mir-21	22770403	PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.	NO
hsa-mir-21	23254774	These data indicated that TPM1 is downregulated in HuCCT1 cells and that the Ras signaling pathway as well as DNA methylation, histone deacetylation and miR-21 upregulation play important roles in the suppression of TPM1 expression in HuCCT1 cells. Thus, compounds that inhibit genetic and epigenetic mechanisms may be promising agents in treating cholangiocarcinoma.	NO
hsa-mir-21	23480766	The expression level of miR-21 had an inverse correlation with the mRNA level of its target RECK, a metastasis suppressor, in human CCA	NO
hsa-mir-21	23621247	MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.	NO
hsa-mir-21	24699315	miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.	YES
hsa-mir-21	25803229	MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.	YES
hsa-mir-21	26191158	MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.	YES
hsa-mir-21	30050323	miR-21 may be a promising biomarker for diagnosis and prognosis of CCA	NO
hsa-mir-21	16762633	MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes.	NO
hsa-mir-21	17531469	Recently Meng et al. showed that miR-21 is also overexpressed in malignant cholangiocarcinomas, a highly chemoresistant cancer type, knockdown of miR-21 sensitised cholangiocarcinoma cell lines for treatment with gemcitabin, whereas transfection of non-malignant cholangiocytes with precursor miR-21 made cells more resistant to gemcitabin.	NO
hsa-mir-21	19296468	miR-21: overexpressed	NO
hsa-mir-210	29953500	Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.	NO
hsa-mir-210	30214622	Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.	NO
hsa-mir-214	22540680	Downregulated miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist.	YES
hsa-mir-214	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-216a	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-216b	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-217	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-22	29406621	MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.	NO
hsa-mir-221	27685844	Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.	NO
hsa-mir-221	24918778	Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	NO
hsa-mir-221	27280413	no correlation was found between the expression levels of these molecular markers and histopathological differentiation grade.	NO
hsa-mir-221	24147037	miRNA expression profiling was used to identify key miRNAs that regulate Gem sensitivity in CCA cells, and software that predicts miRNA targets was used to identify promising target genes for anti-tumor therapies.	NO
hsa-mir-222	26864161	a difference in the expression of miR-222 and miR-483-5p in CC versus PSC	NO
hsa-mir-224	26573191	IL-6 may promote the invasive and metastatic properties of CCA through upregulated miR-224. Studies of the differentially expressed serum miRNAs in CCA may help to further elucidate the pathogenic processes of this disease and aid in the development of a novel and effective therapeutic strategy.	NO
hsa-mir-24	28087162	miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.	NO
hsa-mir-25	21953056	miR-25 targets TRAIL death Receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.	NO
hsa-mir-25	28098904	has-miR-96, has-miR-1 and has-miR-25, may be potential therapeutic targets for the future treatment of ICC	NO
hsa-mir-26a	26087181	Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.	NO
hsa-mir-26a	25691459	Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.	NO
hsa-mir-26a-1	22484120	MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating beta-catenin.	YES
hsa-mir-26a-2	22484120	MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating beta-catenin.	YES
hsa-mir-26b	25691459	Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.	NO
hsa-mir-29a	26441331	TGF-β1/miR-29a/HDAC4 pathway contributes to the pathogenesis of cholangiocarcinoma and our data provide new therapeutic targets for cholangiocarcinoma.	YES
hsa-mir-29b	24147037	miRNA expression profiling was used to identify key miRNAs that regulate Gem sensitivity in CCA cells, and software that predicts miRNA targets was used to identify promising target genes for anti-tumor therapies.	NO
hsa-mir-30e	29662654	Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition	NO
hsa-mir-320a	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-338	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-34a	28923203	Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.	NO
hsa-mir-34a	26923637	The inhibition of miR-34a decreased proliferation, migration and invasion in cholangiocarcinoma cells.	YES
hsa-mir-34a	26077733	microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.	YES
hsa-mir-370	28545228	Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.	NO
hsa-mir-370	23110045	Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch	YES
hsa-mir-373	21165562	Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar Cholangiocarcinoma.	NO
hsa-mir-373	21086164	miR-373 is one negative regulator of MBD2. In hilar cholangiocarcinoma, down-expression of miR-373 leads to increase of MBD2, which in turn suppresses the methylation-mediated gene such as RASSF1A.	NO
hsa-mir-373	22876037	Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.	NO
hsa-mir-376c	23922722	MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.	YES
hsa-mir-383	30145803	miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.	YES
hsa-mir-429	27593557	Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.	NO
hsa-mir-429	30165035	the hsa-miR-205-5p and miR-200 family members were markedly up-regulated for 600-1500 folds, whereas the miR-199 family members and their clustered miRNA, hsa-miR-214-3p, were down-regulated for 1000-2000 folds	NO
hsa-mir-433	29406621	MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.	NO
hsa-mir-483	26864161	whereas miR-483-5p and miR-194 showed deregulated expression in CC compared with controls	NO
hsa-mir-483	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-494	22785131	Coordinated effects of microRNA-494 induce G/M arrest in human cholangiocarcinoma.	NO
hsa-mir-494	30314946	MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.	NO
hsa-mir-494	21809359	miRNA-494 downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint.	NO
hsa-mir-505	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-5095	29620172	Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.	YES
hsa-mir-513	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-605	25131931	MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.	YES
hsa-mir-605	25131931	MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.	YES
hsa-mir-652	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-675	25880914	In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.	NO
hsa-mir-874	25903557	The association of unique miRNA profiles with different ICC subtypes suggests the involvement of specific miRNAs during ICC tumor progression. In plasma, an eight-miRNA signature associated with ICC could form the foundation of an accessible (plasma-based) miRNA-based biomarker for the early detection of ICC.	NO
hsa-mir-92-1	25239565	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.	YES
hsa-mir-92b	29749758	The high level of miR-92b was associated with adverse outcomes in cholangiocarcinoma patients	NO
hsa-mir-96	28098904	has-miR-96, has-miR-1 and has-miR-25, may be potential therapeutic targets for the future treatment of ICC	NO
